- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02727660
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
September 3, 2019 updated by: Pearl Therapeutics, Inc.
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
This is a Phase III randomized, double-blind, parallel group, multi-center, 52-week COPD exacerbation and lung function study with PT009 320/9.6 μg, PT009 160/9.6 μg and PT005 9.6 μg, all administered BID.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a Phase III randomized, double-blind, parallel group, multi-center, 52-week COPD exacerbation and lung function study.
Subjects will undergo a 1- to 4-week Screening Period.
Subjects who successfully complete the Screening Period will be randomized to one of the following three treatment groups: PT009 320/9.6 μg, PT009 160/9.6 μg and PT005 9.6 μg, all administered BID.
Following randomization, subjects will enter the Treatment Period and undergo additional treatment visits over 52 weeks.
Study Type
Interventional
Enrollment (Actual)
1876
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Buenos Aires, Argentina, C1414AIF
- Research Site
-
Caba, Argentina
- Research Site
-
Caba, Argentina, C1425BEN
- Research Site
-
Caba, Argentina, C1056ABJ
- Research Site
-
Caba, Argentina, 1426
- Research Site
-
Ciudad Autonomade Buenos Aires, Argentina, 1426
- Research Site
-
Ciudad Autónoma de Buenos Aire, Argentina, C1440BRR
- Research Site
-
Ciudad de Buenos Aires, Argentina, 1425
- Research Site
-
Concepción del Uruguay, Argentina, 3260
- Research Site
-
Córdoba, Argentina, X5003DCE
- Research Site
-
Florencio Varela, Argentina, 1888
- Research Site
-
Mar del Plata, Argentina, 7600
- Research Site
-
Mar del Plata, Argentina, B7600GNY
- Research Site
-
Mar del Plata, Argentina, B7600FZN
- Research Site
-
Mendoza, Argentina, 5500
- Research Site
-
Mendoza, Argentina, M5500GIP
- Research Site
-
Nueve de julio, Argentina, B6500EZL
- Research Site
-
Ranelagh, Argentina, 1886
- Research Site
-
Rosario, Argentina, S2000DEJ
- Research Site
-
San Fernando, Argentina, 1646
- Research Site
-
San Miguel de Tucuman, Argentina, 4000
- Research Site
-
-
-
-
-
Bludenz, Austria, 6700
- Research Site
-
Feldbach, Austria, A-8330
- Research Site
-
Hallein, Austria, 5400
- Research Site
-
Linz, Austria, 04020
- Research Site
-
-
-
-
-
Brussels, Belgium, 1070
- Research Site
-
Erpent, Belgium, 5101
- Research Site
-
Gilly, Belgium, 6060
- Research Site
-
Jambes, Belgium, 5100
- Research Site
-
Liège, Belgium, 4000
- Research Site
-
Roeselare, Belgium, 8800
- Research Site
-
-
-
-
-
Botucatu, Brazil, 18618-970
- Research Site
-
Porto Alegre, Brazil, 90610-000
- Research Site
-
Porto Alegre, Brazil, 91350-200
- Research Site
-
Porto Alegre, Brazil, 90470-340
- Research Site
-
Porto Alegre, Brazil, 90035074
- Research Site
-
Santo Andre, Brazil, 09080-110
- Research Site
-
Sao Bernardo do Campo, Brazil, 09750-420
- Research Site
-
Sao Paulo, Brazil, 04039-901
- Research Site
-
Sorocaba, Brazil, 18040-425
- Research Site
-
São Paulo, Brazil, 01228-200
- Research Site
-
Uberlandia, Brazil, 38411-186
- Research Site
-
Vitória, Brazil, 29055-450
- Research Site
-
-
-
-
-
Quebec, Canada, G1V 4G5
- Research Site
-
Quebec, Canada, G2J 0C4
- Research Site
-
-
Ontario
-
Ajax, Ontario, Canada, L1S 2J5
- Research Site
-
Windsor, Ontario, Canada, N8X 1T3
- Research Site
-
Windsor, Ontario, Canada, N8X 5A6
- Research Site
-
-
Quebec
-
St Charles Borromee, Quebec, Canada, J6E 2B4
- Research Site
-
Trois-Rivières, Quebec, Canada, G8T 7A1
- Research Site
-
-
-
-
-
Curico, Chile, 3341643
- Research Site
-
Santiago, Chile, 8380456
- Research Site
-
Santiago, Chile, 8380453
- Research Site
-
Talca, Chile, 3465584
- Research Site
-
Talcahuano, Chile, 4270918
- Research Site
-
-
-
-
-
Aarhus N, Denmark, 8200
- Research Site
-
Hvidovre, Denmark, 2650
- Research Site
-
Kolding, Denmark, 6000
- Research Site
-
København NV, Denmark, 2400
- Research Site
-
Odense C, Denmark, 5000
- Research Site
-
Roskilde, Denmark, 4000
- Research Site
-
Silkeborg, Denmark, 8600
- Research Site
-
Ålborg, Denmark, 9000
- Research Site
-
-
-
-
-
Berlin, Germany, 14059
- Research Site
-
Berlin, Germany, 10119
- Research Site
-
Berlin, Germany, 12157
- Research Site
-
Berlin, Germany, 13187
- Research Site
-
Cottbus, Germany, 03044
- Research Site
-
Frankfurt, Germany, 60596
- Research Site
-
Köln, Germany, 51069
- Research Site
-
Leipzig, Germany, 04357
- Research Site
-
Lübeck, Germany, 23552
- Research Site
-
Rodgau-Dudenhofen, Germany, 63110
- Research Site
-
-
-
-
-
Bari, Italy, 70124
- Research Site
-
Catania, Italy, 95123
- Research Site
-
Ferrara, Italy, 44121
- Research Site
-
Legnago, Italy, 37045
- Research Site
-
Monza, Italy, 20900
- Research Site
-
Napoli, Italy, 80131
- Research Site
-
Padova, Italy, 35128
- Research Site
-
Pavia, Italy, 27100
- Research Site
-
Riccione, Italy, 47838
- Research Site
-
Rimini, Italy, 47921
- Research Site
-
Roma, Italy, 00168
- Research Site
-
Roma, Italy, 00100
- Research Site
-
Sassari, Italy, 07100
- Research Site
-
-
-
-
-
Cdmx, Mexico, 6760
- Research Site
-
Durango, Mexico, 43080
- Research Site
-
Guadalajara, Mexico, 44130
- Research Site
-
Guadalajara, Mexico, 44200
- Research Site
-
Guadalajara, Mexico, 44100
- Research Site
-
Minatitlán, Mexico, 96730
- Research Site
-
Monterrey, Mexico, 64460
- Research Site
-
Sonora, Mexico, 83000
- Research Site
-
Villahermosa, Mexico, 86035
- Research Site
-
-
-
-
-
Arendal, Norway, 4841
- Research Site
-
Hønefoss, Norway, N-3515
- Research Site
-
Kråkeroy, Norway, N-1671
- Research Site
-
Stavanger, Norway, N-4005
- Research Site
-
Svelvik, Norway, 3060
- Research Site
-
Trondheim, Norway, 7030
- Research Site
-
-
-
-
-
Chancay, Peru, 15131
- Research Site
-
Cusco, Peru
- Research Site
-
Lima, Peru, L27
- Research Site
-
Lima, Peru, LIMA 1
- Research Site
-
Lima, Peru, LIMA 31
- Research Site
-
Lima, Peru, 41
- Research Site
-
Lima, Peru, Lima 32
- Research Site
-
Lima, Peru, L41
- Research Site
-
Lima, Peru, L18
- Research Site
-
Lima, Peru, LIMA 21
- Research Site
-
Piura, Peru
- Research Site
-
-
-
-
-
Ponce, Puerto Rico, 00717
- Research Site
-
San Juan, Puerto Rico, 00927
- Research Site
-
-
-
-
-
Ekaterinburg, Russian Federation, 620039
- Research Site
-
Izhevsk, Russian Federation, 426035
- Research Site
-
Moscow, Russian Federation, 105077
- Research Site
-
Novosibirsk, Russian Federation, 630008
- Research Site
-
Novosibirsk, Russian Federation, 630084
- Research Site
-
Omsk, Russian Federation, 644043
- Research Site
-
Penza, Russian Federation, 440067
- Research Site
-
Perm, Russian Federation, 614000
- Research Site
-
Saint Petersburg, Russian Federation, 196601
- Research Site
-
Saint-Petersburg, Russian Federation, 197022
- Research Site
-
StPetersburg, Russian Federation, 191180
- Research Site
-
Ulyanovsk, Russian Federation, 432009
- Research Site
-
-
-
-
-
Bloemfontein, South Africa, 9301
- Research Site
-
Cape Town, South Africa, 7764
- Research Site
-
Cape Town, South Africa, 7570
- Research Site
-
Cape Town, South Africa, 1730
- Research Site
-
Durban, South Africa, 4001
- Research Site
-
Johannesburg, South Africa, 2001
- Research Site
-
Lenasia Ext8, South Africa, 1820
- Research Site
-
Mowbray, South Africa, 7700
- Research Site
-
Parow, South Africa
- Research Site
-
Pretoria, South Africa, 184
- Research Site
-
Stanger, South Africa, 4450
- Research Site
-
-
-
-
-
Alicante, Spain, 03114
- Research Site
-
Alzira (Valencia), Spain, 46600
- Research Site
-
Benalmádena (Málaga), Spain, 29631
- Research Site
-
Cáceres, Spain, 10003
- Research Site
-
Jerez de la Frontera, Spain, 11407
- Research Site
-
Laredo, Spain, 39770
- Research Site
-
Loja (Granada), Spain, 18300
- Research Site
-
Malaga, Spain, 29010
- Research Site
-
Marbella (Málaga), Spain, 29603
- Research Site
-
Palma de Mallorca, Spain, 07010
- Research Site
-
Sagunto(Valencia), Spain, 46520
- Research Site
-
Sant Boi de Llobregat, Spain, 08830
- Research Site
-
-
-
-
-
Lund, Sweden, 221 85
- Research Site
-
Lund, Sweden, 222 21
- Research Site
-
Malmo, Sweden, 21152
- Research Site
-
Stockholm, Sweden, 114 46
- Research Site
-
Uppsala, Sweden, 75237
- Research Site
-
-
-
-
-
Bradford, United Kingdom, BD9 6RJ
- Research Site
-
Chertsey, United Kingdom, KT16 0PZ
- Research Site
-
Chester, United Kingdom, CH2 1UL
- Research Site
-
Doncaster, United Kingdom, DN2 5LT
- Research Site
-
Lancaster, United Kingdom, LA1 4RP
- Research Site
-
Sheffield, United Kingdom, S5 7AU
- Research Site
-
Wishaw, United Kingdom, ML2 0DP
- Research Site
-
-
-
-
Alabama
-
Dothan, Alabama, United States, 36305
- Research Site
-
Huntsville, Alabama, United States, 35801
- Research Site
-
Sheffield, Alabama, United States, 35660
- Research Site
-
-
Arizona
-
Flagstaff, Arizona, United States, 86001
- Research Site
-
-
California
-
Costa Mesa, California, United States, 92627
- Research Site
-
Gold River, California, United States, 95670
- Research Site
-
Lincoln, California, United States, 95648
- Research Site
-
Long Beach, California, United States, 90822
- Research Site
-
Palo Alto, California, United States, 94304
- Research Site
-
San Diego, California, United States, 92120
- Research Site
-
San Diego, California, United States, 92103
- Research Site
-
San Diego, California, United States, 92117
- Research Site
-
Upland, California, United States, 91786
- Research Site
-
Yorba Linda, California, United States, 92886
- Research Site
-
-
Colorado
-
Boulder, Colorado, United States, 80301
- Research Site
-
Denver, Colorado, United States, 80246
- Research Site
-
-
Connecticut
-
New Haven, Connecticut, United States, 06716
- Research Site
-
-
Florida
-
Boynton Beach, Florida, United States, 33472
- Research Site
-
Chiefland, Florida, United States, 32626
- Research Site
-
Clearwater, Florida, United States, 33765
- Research Site
-
Daytona Beach, Florida, United States, 32117
- Research Site
-
Hialeah, Florida, United States, 33012
- Research Site
-
Kissimmee, Florida, United States, 34741
- Research Site
-
Leesburg, Florida, United States, 34748
- Research Site
-
Lehigh Acres, Florida, United States, 33971
- Research Site
-
Merritt Island, Florida, United States, 32952
- Research Site
-
Miami, Florida, United States, 33126
- Research Site
-
Miami, Florida, United States, 33173
- Research Site
-
Miami, Florida, United States, 33165
- Research Site
-
Miami, Florida, United States, 33145
- Research Site
-
Miami, Florida, United States, 33155
- Research Site
-
Orlando, Florida, United States, 32825
- Research Site
-
Ormond Beach, Florida, United States, 32174
- Research Site
-
Port Orange, Florida, United States, 32127
- Research Site
-
Sarasota, Florida, United States, 34239
- Research Site
-
Tampa, Florida, United States, 33603
- Research Site
-
Tampa, Florida, United States, 33607
- Research Site
-
Winter Park, Florida, United States, 32789
- Research Site
-
-
Georgia
-
Atlanta, Georgia, United States, 30345
- Research Site
-
Dacula, Georgia, United States, 30019
- Research Site
-
Decatur, Georgia, United States, 30033
- Research Site
-
Snellville, Georgia, United States, 30078
- Research Site
-
Stockbridge, Georgia, United States, 30281
- Research Site
-
-
Illinois
-
Aurora, Illinois, United States, 60506
- Research Site
-
Chicago, Illinois, United States, 60607
- Research Site
-
Peoria, Illinois, United States, 61602
- Research Site
-
-
Indiana
-
Brownsburg, Indiana, United States, 46112
- Research Site
-
Evansville, Indiana, United States, 47714
- Research Site
-
Valparaiso, Indiana, United States, 46383
- Research Site
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- Research Site
-
-
Kansas
-
Olathe, Kansas, United States, 66061
- Research Site
-
Topeka, Kansas, United States, 66604
- Research Site
-
-
Kentucky
-
Hazard, Kentucky, United States, 41701
- Research Site
-
-
Louisiana
-
Metairie, Louisiana, United States, 70006
- Research Site
-
Sunset, Louisiana, United States, 70584
- Research Site
-
-
Maine
-
Biddeford, Maine, United States, 04005
- Research Site
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Research Site
-
-
Missouri
-
Chesterfield, Missouri, United States, 63017
- Research Site
-
Kansas City, Missouri, United States, 64128
- Research Site
-
Saint Charles, Missouri, United States, 63301
- Research Site
-
Saint Louis, Missouri, United States, 63122
- Research Site
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68510
- Research Site
-
-
Nevada
-
Reno, Nevada, United States, 89506
- Research Site
-
-
New Jersey
-
Toms River, New Jersey, United States, 08755
- Research Site
-
-
New York
-
Bronx, New York, United States, 10459
- Research Site
-
Brooklyn, New York, United States, 11215
- Research Site
-
New York, New York, United States, 10029
- Research Site
-
Syracuse, New York, United States, 13210
- Research Site
-
-
North Carolina
-
Gastonia, North Carolina, United States, 28054
- Research Site
-
Hickory, North Carolina, United States, 28602
- Research Site
-
Hickory, North Carolina, United States, 28601
- Research Site
-
Lenoir, North Carolina, United States, 28645
- Research Site
-
Tabor City, North Carolina, United States, 28463
- Research Site
-
Winston-Salem, North Carolina, United States, 27104
- Research Site
-
-
Ohio
-
Canton, Ohio, United States, 44718
- Research Site
-
Cincinnati, Ohio, United States, 45242
- Research Site
-
Columbus, Ohio, United States, 43213
- Research Site
-
Columbus, Ohio, United States, 43207
- Research Site
-
Dayton, Ohio, United States, 45417
- Research Site
-
Marion, Ohio, United States, 43302
- Research Site
-
Wooster, Ohio, United States, 44691
- Research Site
-
-
Oklahoma
-
Edmond, Oklahoma, United States, 73034
- Research Site
-
-
Oregon
-
Medford, Oregon, United States, 97504
- Research Site
-
Portland, Oregon, United States, 97220
- Research Site
-
-
Pennsylvania
-
Johnstown, Pennsylvania, United States, 15905
- Research Site
-
Scottdale, Pennsylvania, United States, 15683
- Research Site
-
Wyomissing, Pennsylvania, United States, 19610
- Research Site
-
-
Rhode Island
-
Cumberland, Rhode Island, United States, 02864
- Research Site
-
East Providence, Rhode Island, United States, 02914
- Research Site
-
Warwick, Rhode Island, United States, 02886
- Research Site
-
-
South Carolina
-
Anderson, South Carolina, United States, 29621
- Research Site
-
Gaffney, South Carolina, United States, 29340
- Research Site
-
Gaffney, South Carolina, United States, 29341
- Research Site
-
Lancaster, South Carolina, United States, 29720
- Research Site
-
Orangeburg, South Carolina, United States, 29118
- Research Site
-
Rock Hill, South Carolina, United States, 29732
- Research Site
-
Seneca, South Carolina, United States, 29678
- Research Site
-
Spartanburg, South Carolina, United States, 29303
- Research Site
-
-
Tennessee
-
Franklin, Tennessee, United States, 37067
- Research Site
-
Knoxville, Tennessee, United States, 37909
- Research Site
-
Smyrna, Tennessee, United States, 37167
- Research Site
-
-
Texas
-
Amarillo, Texas, United States, 79106
- Research Site
-
Austin, Texas, United States, 78758
- Research Site
-
Baytown, Texas, United States, 77521
- Research Site
-
Dallas, Texas, United States, 75234
- Research Site
-
Houston, Texas, United States, 77030
- Research Site
-
Kerrville, Texas, United States, 78028
- Research Site
-
Lewisville, Texas, United States, 75067
- Research Site
-
Lufkin, Texas, United States, 75904
- Research Site
-
McKinney, Texas, United States, 75069
- Research Site
-
McKinney, Texas, United States, 75070
- Research Site
-
Plano, Texas, United States, 75093
- Research Site
-
Port Arthur, Texas, United States, 77640
- Research Site
-
Sherman, Texas, United States, 75092
- Research Site
-
Spring, Texas, United States, 77379
- Research Site
-
Waco, Texas, United States, 76712
- Research Site
-
-
Utah
-
Salt Lake City, Utah, United States, 94102
- Research Site
-
-
Virginia
-
Manassas, Virginia, United States, 20110
- Research Site
-
-
Washington
-
Everett, Washington, United States, 98208
- Research Site
-
Renton, Washington, United States, 98055
- Research Site
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Research Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Give their signed written informed consent to participate
- At least 40 years of age and no older than 80 years of age
- COPD patients who are symptomatic
- Must be receiving one or more inhaled bronchodilators as maintenance therapy
- Must have a documented history of COPD exacerbations
Exclusion Criteria:
- Current diagnosis of asthma
- COPD due to α1-Antitrypsin Deficiency
- Known active tuberculosis, lung cancer, cystic fibrosis, and significant bronchiectasis, Pulmonary resection or Lung Volume Reduction Surgery during the past 6 months.
- Long-term-oxygen therapy (≥ 15 hours a day).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: BFF MDI (PT009) 320/9.6 μg
Budesonide and Formoterol Fumarate Inhalation Aerosol - 160/4.8 μg per actuation MDI/120 inhalations Taken as 2 inhalations BID
|
Blinded Treatment
Other Names:
|
|
EXPERIMENTAL: BFF MDI (PT009) 160/9.6 μg
Budesonide and Formoterol Fumarate Inhalation Aerosol - 80/4.8 μg per actuation MDI/120 inhalations Taken as 2 inhalations BID
|
Blinded Treatment
Other Names:
|
|
EXPERIMENTAL: FF MDI (PT005) 9.6 μg
Formoterol Fumarate Inhalation Aerosol - 4.8 μg per actuation MDI/120 inhalations Taken as 2 inhalations BID
|
Blinded Treatment
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Morning Pre-dose Trough FEV1
Time Frame: at Week 12
|
Morning pre-dose trough FEV1 (Forced Expiratory Volume in one second) at week 12
|
at Week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to First Moderate or Severe COPD Exacerbation
Time Frame: over 52 weeks
|
Time to first moderate or severe COPD (Chronic Obstructive Pulmonary Disease) exacerbation over 52 weeks
|
over 52 weeks
|
|
Change From Baseline in Average Daily Rescue Ventolin HFA Use
Time Frame: over 12 weeks
|
Change from baseline in average daily rescue Ventolin HFA use over 12 weeks
|
over 12 weeks
|
|
Percentage of Subjects Achieving an MCID (Minimal Clinically Important Difference) of 4 Units or More in Saint George's Respiratory Questionnaire (SGRQ) Total Score
Time Frame: at Week 12
|
The SGRQ (St.
George's Respiratory Questionnaire) is a disease-specific questionnaire, self-completed by participants, used to evaluate the effect of BFF MDI on health-related quality of life as compared to FF MDI in subjects with COPD.
The scores range from 0 (minimum, best possible health status) to 100 (maximum, worst possible health status).
The SGRQ contains 76 items grouped into three domains (symptoms, activity and impacts).
Change from Baseline at a particular visit was calculated as the SGRQ total score at that visit minus Baseline.
A decrease from baseline in SGRQ total score of 4 units or more is considered a clinically meaningful improvement in quality of life.
|
at Week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 29, 2016
Primary Completion (ACTUAL)
April 4, 2018
Study Completion (ACTUAL)
April 4, 2018
Study Registration Dates
First Submitted
March 30, 2016
First Submitted That Met QC Criteria
March 30, 2016
First Posted (ESTIMATE)
April 4, 2016
Study Record Updates
Last Update Posted (ACTUAL)
September 26, 2019
Last Update Submitted That Met QC Criteria
September 3, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Lung Diseases
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Anti-Inflammatory Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Adrenergic Agonists
- Bronchodilator Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Adrenergic beta-2 Receptor Agonists
- Adrenergic beta-Agonists
- Budesonide
- Formoterol Fumarate
Other Study ID Numbers
- PT009003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disorder
-
Universitätsmedizin MannheimUnknownPulmonary Emphysema | COPD | Obstructive Ventilation DisorderGermany
-
University Hospital, CataniaUnknownDepression in Patients With Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
COPD FoundationKaiser Foundation Hospitals, Center for Health ResearchRecruitingEmphysema | Chronic Bronchitis | Chronic Obstructive Lung Disease | Chronic Obstructive Pulmonary DisorderUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Czechia
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Nestor Soler Porcar, MD, PhDCompletedDepression | Chronic Obstructive Pulmonary Disease | AnxietySpain
Clinical Trials on BFF MDI (PT009) 320/9.6 μg
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pearl Therapeutics, Inc.CompletedCOPDUnited States, Austria, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Peru, Russian Federation, Hungary, China, Taiwan, Australia, Japan, Argentina, South Africa, Belgium, Czechia, Serbia, Poland, Mexico, New... and more
-
Pearl Therapeutics, Inc.Completed
-
AstraZenecaCompletedAsthmaUnited States, Brazil, China, Germany, Israel, Russian Federation, South Africa, Turkey, Portugal, Greece, Czechia, Slovakia, Mexico, United Kingdom, Colombia, Puerto Rico
-
Pearl Therapeutics, Inc.Completed
-
AstraZenecaCompletedAsthmaUnited States, Belgium, Canada, Italy, Spain, Thailand, Vietnam, Korea, Republic of, India, Philippines, Taiwan, New Zealand, Japan, Argentina, Poland, Bulgaria, Hungary, Romania, Peru, Puerto Rico, Chile
-
AstraZenecaCompletedAsthmaUnited States, Canada, Italy, Vietnam, Spain, Germany, Japan
-
Pearl Therapeutics, Inc.WithdrawnChronic Obstructive Pulmonary Disease
-
AstraZenecaCompletedAsthmaUnited States, Canada, Philippines, Malaysia, South Africa, Czechia, South Korea
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Germany, Argentina, Bulgaria, Poland, Mexico, United Kingdom, Turkey (Türkiye)